Related Experiment Video
Updated: Nov 3, 2025

A Rat Model of EcoHIV Brain Infection
Published on: January 21, 2021
Modeling Intracellular Delay in Within-Host HIV Dynamics Under Conditioning of Drugs of Abuse
Naveen K Vaidya1, Michael Peter2
1Department of Mathematics and Statistics, Computational Science Research Center, Viral Information Institute, San Diego State University, 5500 Campanile Dr, San Diego, CA, 92182, USA. nvaidya@sdsu.edu.
Abstract:
Drugs of abuse, such as opiates, have been widely associated with the enhancement of HIV replication, the acceleration of disease progression, and severe neuropathogenesis. Specifically, the presence of drugs of abuse (morphine) switches target cells (CD4[Formula: see text] T cells) from lower-to-higher susceptibility to HIV infection. The effect of such switching behaviors on viral dynamics may be altered due to the intracellular delay (the replication time between viral entry into a target cell and the production of new viruses by the infected cell). In this study, we develop, for the first time, a viral dynamics model that includes an intracellular delay under the conditioning of drugs of abuse. We parameterize the model using experimental data from simian immunodeficiency virus infection of morphine-addicted macaques. Results from thorough mathematical analyses and numerical simulations of our model show that the intracellular delay can play a significant role in HIV dynamics under the conditioning of drugs of abuse, particularly during the acute phase of infection. Our model and the related results provide new insights into the HIV dynamics and may help develop strategies to control HIV infections in drug abusers.
Related Concept Videos
Drug Dependence
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Retrovirus Life Cycles

